Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MeiraGTx Holdings plc(MGTX) | 12,197,737 | 12,197,737 | 0 | $82.70M | $79.53M | 45.25% | -$3.17M |
| Novavax, Inc.(NVAX) | 6,880,481 | 6,880,481 | 0 | $44.10M | $43.35M | 24.67% | -$756.9K |
| AnaptysBio | 821,917 | 821,917 | 0 | $15.28M | $18.25M | 10.38% | +$2.97M |
| Inhibrx Biosciences, Inc.(INBX) | 1,157,926 | 1,157,926 | 0 | $16.20M | $16.52M | 9.40% | +$324.2K |
| Omada Health, Inc.(OMDA) | 0 | 524,903 | +524,903 | $0 | $9.61M | 5.47% | +$9.61M |
| LAVA Therapeutics N.V.SHS | 1,919,455 | 1,919,455 | 0 | $2.44M | $2.53M | 1.44% | +$96.0K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 814,980 | 814,980 | 0 | $2.76M | $2.21M | 1.26% | -$554.2K |
| Inozyme, Inc | 443,255 | 443,255 | 0 | $403.4K | $1.77M | 1.01% | +$1.37M |
| IGM Biosciences | 1,438,975 | 1,438,975 | 0 | $1.65M | $1.61M | 0.92% | -$43.2K |
| Q32 Bio Inc.(QTTB) | 244,083 | 244,083 | 0 | $402.7K | $363.7K | 0.21% | -$39.1K |